Journals Library


HTA - 06/303/84

Randomised controlled trial of tumour-necrosis-factor inhibitors against combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: the TACIT trial

Project title: Randomised controlled trial of tumour-necrosis-factor inhibitors against combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: the TACIT trial

Call to action: 06/303 HTA Clinical Trials - Pharmaceutical Panel

Research type: Primary Research

Chief investigator: Professor David ScottORCID logoorcid.org/0000-0002-2198-4913

Lead Author: Professor David ScottORCID logoorcid.org/0000-0002-2198-4913

Contractor: King's College London

Cost: £769,913.00

Co-investigators: Dr Andrew Hassell, Dr David Walker, Dr Gabrielle Kingsley, Ms Claire Smith, Professor Ernest Choy, Professor Vern Farewell.

Started: April 2007 | Status: Published October 2014

ISRCTN: 37438295

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.

Background & Research Questions

Why the research is being done and what is being asked

Methods

How the research is being done

Publications & Outputs

What the research produced

Outcomes & Impact

What happened as a result of the research

If you would like to receive a notification when this project is updated, please submit your email address below. This will also notify you when the Journals Library report is published.